Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Baozheng Li"'
Publikováno v:
Human Gene Therapy Methods. 27:143-149
We have described the development of capsid-modified next-generation AAV vectors for both AAV2 and AAV3 serotypes, in which specific surface-exposed tyrosine (Y), serine (S), threonine (T), and lysine (K) residues on viral capsids were modified to ac
Autor:
Changquan Ling, Xiao Xiao, Thomas B. Lentz, Chen Ling, Binbin Cheng, George Aslanidi, Baozheng Li, R. Jude Samulski, Giridhara R. Jayandharan, Yuan Wang, Yuan Lu, Wenqin Ma, Arun Srivastava, Lina Wang, Nicholas Muzyczka
Publikováno v:
Journal of molecular and genetic medicine : an international journal of biomedical research. 9(3)
Chen Ling1,2, Yuan Wang1-3, Yuan Lu4, Lina Wang1-3, Giridhara R Jayandharan5, George V Aslanidi1,2, Baozheng Li1,2, Binbin Cheng1,3, Wenqin Ma1,2, Thomas Lentz6, Changquan Ling3, Xiao Xiao6,7, R Jude Samulski6, Nicholas Muzyczka2,8,9 and Arun Srivast
Publikováno v:
Human Gene Therapy. 22:633-640
We have recently shown that co-administration of conventional single-stranded adeno-associated virus 2 (ssAAV2) vectors with self-complementary (sc) AAV2-protein phosphatase 5 (PP5) vectors leads to a significant increase in the transduction efficien
Autor:
Seok-Hong Min, Alfred S. Lewin, Li Zhong, Antonette Bennett, Hilda Petrs-Silva, William W. Hauswirth, Giridhara R. Jayandharan, Mavis Agbandje-McKenna, Jijing Pang, Andy W. Neeley, Arun Srivastava, Astra Dinculescu, Qiuhong Li, Wen-Tao Deng, Lakshmanan Govindasamy, Baozheng Li, Vince A. Chiodo
Publikováno v:
Molecular Therapy. 19(2):293-301
Vectors based on adeno-associated virus serotype 2 (AAV2) have been used extensively in many gene-delivery applications, including several successful clinical trials for one type of Leber congenital amaurosis in the retina. Many studies have focused
Autor:
Li Zhong, Roland W. Herzog, Baozheng Li, Giridhara R. Jayandharan, Mengxin Li, Brandon K. Sack, Arun Srivastava, Angela Rivers
Publikováno v:
Human Gene Therapy. 21:271-283
Our studies have shown that coinjection of conventional single-stranded adeno-associated virus 2 (ssAAV2) vectors carrying the enhanced green fluorescent protein (EGFP) gene with self-complementary (sc) AAV2-T cell protein tyrosine phosphatase (TC-PT
Autor:
Li Zhong, Nicholas Muzyczka, Sergei Zolotukhin, Lakshmanan Govindasamy, Giridhararao Jayandharan, Kirsten A. Weigel-Van Aken, Roland W. Herzog, Cathryn Mah, Baozheng Li, Arun Srivastava, Mavis Agbandje-McKenna, Jacqueline A. Hobbs
Publikováno v:
Virology. 381(2):194-202
We have documented that epidermal growth factor receptor protein tyrosine kinase (EGFR-PTK) signaling negatively affects intracellular trafficking and transduction efficiency of recombinant adeno-associated virus 2 (AAV2) vectors. Specifically, inhib
Autor:
Baozheng Li, Zongchao Han, Arun Srivastava, Li Zhong, Kenneth H. Warrington, Wenqin Ma, Kirsten A. Weigel-Kelley, Weihong Zhao, Jianqing Wu
Publikováno v:
Human Gene Therapy. 18:171-182
Self-complementary adeno-associated viral (scAAV) vectors bypass the requirement for viral second-strand DNA synthesis, but the packaging capacity of these vectors ( approximately 2.4 kb) is significantly smaller than that of conventional AAV vectors
Autor:
Arun Srivastava, Baozheng Li, Lin Ya Huang, Wenqin Ma, Mavis Agbandje-McKenna, George Aslanidi, Kim Van Vliet, Chen Ling
Publikováno v:
Human gene therapy methods. 26(6)
The ubiquitin-proteasome pathway plays a critical role in the intracellular trafficking of recombinant adeno-associated virus 2 (AAV2) vectors, which negatively impacts the transduction efficiency of these vectors. Because ubiquitination occurs on ly
Autor:
Xiaomiao Li, Mervin C. Yoder, Baozheng Li, Arun Srivastava, Daniela Bischof, Li Zhong, Kenneth H. Warrington, Irene Zolotukhin, Keyun Qing, Njeri Maina, Weihong Zhao, Yanjun Li, Weiming Li, William B. Slayton, Jianqing Wu, Kirsten A. Weigel-Kelley
Publikováno v:
Human Gene Therapy. 17:321-333
Conflicting data exist on hematopoietic cell transduction by AAV serotype 2 (AAV2) vectors, and additional AAV serotype vectors have not been evaluated for their efficacy in hematopoietic stem/progenitor cell transduction. We evaluated the efficacy o
Publikováno v:
Molecular Therapy. 24:S39-S40
There is little doubt that AAV did not evolve for the purposes of delivery of therapeutic genes. The use of first generation AAV vectors, albeit successful, is unlikely to reach its full potential. We have described the development of capsid-modified